iPLEDGE, explained: what isotretinoin actually requires, and why

July 18, 2026 · William S. Farmer, MD

Current as of July 2026. The iPLEDGE program is scheduled to change on November 15, 2026; this article will be updated. Always confirm current requirements with your own prescriber.

If you or your child is starting isotretinoin, you’re about to encounter iPLEDGE, and it will probably feel like the most bureaucratic thing you’ve ever done to get a prescription filled. Monthly visits. Monthly pregnancy tests. A website with comprehension questions. A pickup window measured in days that, if you miss it, sends you back to the start.

Most of the frustration comes from not knowing what the rules actually are. Patients know there’s a window; almost nobody can tell you what starts the clock, what stops it, or which step they’re actually being timed on. So here is the whole thing, plainly – what’s required, why each piece exists, and what changes this November.

One thing worth saying up front: this is a guide to understanding the program, not a substitute for your own prescriber’s instructions. The rules have changed before and are changing again. Your dermatologist’s office is the operative source for your treatment.

First, why any of this exists

Isotretinoin causes severe birth defects. Not “might” – it is one of the most reliably teratogenic drugs in common use, and exposure during pregnancy, even briefly and even at low doses, can cause abnormalities of the face, skull, ears, eyes, heart, central nervous system, and thymus and parathyroid glands, along with increased risk of miscarriage and premature birth. There is no way to test an exposed fetus and know whether it was affected.

That’s the entire reason the program exists. iPLEDGE is a REMS – a Risk Evaluation and Mitigation Strategy – which is the FDA’s mechanism for allowing a drug with serious risks to stay on the market under controlled conditions. Which answers one of the most common questions: how is a drug this dangerous still available? Because for severe, scarring, treatment-resistant acne, it genuinely works when nothing else has, and permanent scarring is itself a serious outcome. The bargain is that access comes with a control system. Every irritating step in iPLEDGE exists to prevent one specific thing: a pregnancy exposed to this drug.

That framing is worth carrying through the rest of this. The rules aren’t arbitrary and they aren’t about doubting you personally.

If you can become pregnant, you cannot start today

This is the expectation that causes the most disappointment, so it’s worth stating plainly and early: deciding you want isotretinoin and actually taking your first capsule are usually about a month apart.

That’s not your dermatologist being slow. It’s built into the program. Before starting, a patient who can become pregnant needs two separate negative pregnancy tests, with a mandatory waiting period between them:

1. A screening test. This can usually be done right in the office at your visit, and a negative result is what allows you to be enrolled in the iPLEDGE system in the first place.
2. A 30-day mandatory waiting period, during which you must be using both of your chosen forms of contraception, consistently.
3. A second confirmatory test from a certified lab, at least 30 days after registration, and timed to the first 5 days of your menstrual cycle. (If you have irregular cycles, no periods, or use a contraceptive that stops withdrawal bleeding, the second test is instead done immediately before starting, after a full month on both forms.)

Only then can treatment begin.

So when someone says “I’m ready, let’s start Accutane,” the honest answer is: excellent – and we start the clock today, with the first pill roughly a month out. Knowing that in advance turns an irritating delay into a plan.

What if I’m not on any birth control yet?

Extremely common, and worth walking through, because there’s one decision that determines how fast everything else moves.

Say you come in for acne, you’ve worked through the usual treatments without success, you’re ready for isotretinoin – and you’re not on contraception of any kind. Here’s how that actually sequences:

• Yes, you can do the screening pregnancy test at that dermatology visit. You don’t have to wait until you’re on birth control to take the first test. That test can be done in the office and gets you enrolled.
• You then need to get contraception started. For most people that means an appointment with a primary care provider or gynecologist to discuss options and get a prescription, since your dermatologist may not be the one managing that.
• The 30-day clock is a contraception clock, not a paperwork clock. It runs from when you are actually using both chosen forms consistently – so it does not start at your dermatology visit, and it does not start when you book the appointment with your PCP. It starts when you’re actually on both methods.

Which produces the single most useful piece of planning advice in this whole article: the rate-limiting step is usually how quickly you can get contraception started, not anything your dermatologist does. If it takes you three weeks to get in with your primary care provider, your isotretinoin start date moves out three weeks with it. So book that appointment first, book it fast, and tell them why you need it – “I’m starting isotretinoin and need two forms of contraception” is a sentence that tends to get people scheduled sooner.

The windows – what they actually are

This causes more missed doses than anything else in the program, almost entirely because people are told “you have a window” and never told what it’s measuring.

Every patient is on a monthly cycle. Prescriptions are limited to a 30-day supply, so you’ll be back roughly every month for as long as you’re on treatment – that part is true whether or not you can become pregnant, and it’s why everyone describes isotretinoin as a monthly commitment.

Separately, there’s the prescription window – and this is the one that catches people out. The window is the time you have to pick up the prescription. That’s the deadline. Everything else – the visit, the pregnancy test, your prescriber entering results, you answering the comprehension questions – has to be finished inside that window so the pharmacy can release the medication before it closes.

How long that window is, and what starts the clock, depends on your category:

• If you can become pregnant: the pickup window is 7 days, and Day 1 is the date your blood or urine sample was collected for the pregnancy test – not your appointment, not the day the prescription was sent. Add 6 days to the collection date and that’s your last day. So you’re managing two timelines at once: the monthly rhythm of visits and tests, and a tight 7-day sprint each month to get the medication in hand.
• If you cannot become pregnant: the pickup window is 30 days, and Day 1 is the office visit date your prescriber enters. Add 29 days for the last day. The monthly cycle and the pickup window are roughly the same length, which is why this group experiences it as much less stressful.

The window closes at 11:59 p.m. Eastern Time on the final day – Eastern, regardless of where you live, which quietly costs West Coast patients three hours they didn’t know they were missing.

Miss it and the prescription can’t be obtained anymore. You start the process over: new test, new confirmation, new comprehension questions, new window.

So, specifically, what “violates” the window: not picking up the medication in time. You can have a perfect visit, a negative test, and a prescription sitting at the pharmacy, and still lose the month by picking it up on day 8. Practical version: treat your pregnancy test date as the start of a one-week countdown, and get to the pharmacy in the first few days, not the last.

The monthly questions

If you can become pregnant, there’s one more monthly step: before you can pick up each prescription, you have to log into the iPLEDGE site and answer questions about the program and about pregnancy prevention. This is a requirement specific to patients who can become pregnant.

They are not a test you can fail permanently, and they’re not designed to trick you – they cover the material you were counseled on. But they are a gate: your prescriber has to enter your test results and contraception first, and then you have to complete the questions, and only then can the pharmacy release the medication. All of that has to happen inside the 7-day window.

The practical failure mode is simple and avoidable: people forget this step exists, assume the pharmacy is just slow, and discover on day 6 that the prescription was never released because the questions were never answered. Do them the same day as your test if you can.

Choose your pharmacy deliberately

This gets almost no attention and it’s one of the highest-leverage decisions you’ll make.

The pharmacy must be iPLEDGE-certified, and it has to actually have isotretinoin in stock, in your dose, inside your window. Being out of stock does not pause the clock. Neither does a staff member who isn’t familiar with the program, or a prescription that sits unprocessed over a weekend.

So pick the pharmacy that is good at this, not the one that’s closest or most convenient. Concretely, that means:

• Call ahead before your first fill and ask whether they regularly dispense isotretinoin and whether they have your dose in stock.
• Prefer a pharmacy where the staff know the program and can tell you immediately whether your authorization has come through.
• Once you find one that handles it smoothly, stay there for the whole course. Switching pharmacies mid-treatment is a reliable way to lose a month.
• If you’re told “it’s not showing up in our system,” call your dermatologist’s office the same day rather than waiting. That’s usually a fixable problem, but only while the window is still open.

A pharmacy five minutes further away that gets it right every month is worth far more than a convenient one that costs you a treatment cycle.

Save your iPLEDGE ID number

When you enroll, you’re assigned a patient identification number. Save it somewhere you’ll actually be able to find it – a note in your phone, a photo of the paperwork, whatever you’ll still have in eight months.

You’d be surprised how often it’s needed: a pharmacy trying to reconcile your record, a new practice picking up your care, a question that comes up months later. Hunting for it while a 7-day window is running is a bad time to discover you never wrote it down.

What changes on November 15, 2026

The FDA approved a set of changes on February 9, 2026 designed to reduce the burden of the program without weakening the pregnancy-prevention core. They were originally set for August 2026; on June 16, 2026 the FDA moved implementation to November 15, 2026 to allow more testing of the iPLEDGE platform so patients’ access wouldn’t be interrupted. (Given the program’s history of delays, confirm the current state with your prescriber rather than assuming.)

What’s changing:

• The 19-day lockout is going away. Currently, if you can become pregnant and you miss the window on your first month, you have to wait at least 19 days from your last pregnancy test before you can test again – because that pre-treatment test has to fall in the first 5 days of your menstrual cycle. It is the single most demoralizing rule in the program: miss a pickup by a day, lose most of a month. Under the new rules, a repeat pregnancy test can be done immediately, with no waiting period.
• At-home pregnancy tests become an option during and after treatment, if your prescriber allows it. The pre-treatment test still has to happen in a medical setting – that one doesn’t change.
• For patients who cannot become pregnant: the requirement for monthly documentation of counseling goes away, as does the 30-day prescription window requirement.
• For pharmacies: clarified annual staff training and record-keeping requirements.

Notably, none of this changes the contraception requirements or the monthly pregnancy testing for patients who can become pregnant. The core of the program stays.

Why monthly visits – including for patients who can’t get pregnant

For patients who can become pregnant, the monthly rhythm is straightforward: a monthly negative pregnancy test is the central safety check, and prescriptions are limited to a 30-day supply so that a fresh test happens before each refill. No stockpiling, no gap where someone is taking the drug without a recent test.

For male patients and others who cannot become pregnant, the honest answer is that it has been partly about program consistency and partly about clinical monitoring – and the program is easing here. The 30-day prescription window and monthly counseling documentation requirements are being removed for this group in November 2026.

That said, your dermatologist may still want to see you regularly, and that’s a separate thing from iPLEDGE. Isotretinoin has real side effects that need watching in anyone taking it. Which brings up the distinction that trips up the most people:

Why bloodwork – and why it is not actually an iPLEDGE rule

iPLEDGE does not require lipid panels, liver function tests, or blood counts. The REMS program’s only lab requirement is pregnancy testing. If you read otherwise online, that source is wrong.

The bloodwork your dermatologist orders is clinical monitoring, which exists for a completely different reason: isotretinoin can raise triglycerides and cholesterol, and can affect liver enzymes. Those changes are usually mild and reversible, but they’re worth catching, and the only way to catch them is to look. Most practices check a baseline and then recheck periodically depending on your results and dose.

So: pregnancy tests are the program. Bloodwork is your doctor taking care of you. Both matter; they’re just not the same system, and conflating them is why people think iPLEDGE is even more onerous than it is.

Contraception – the part with the most confusion

If you can become pregnant, iPLEDGE requires two forms of contraception used simultaneously, starting one month before treatment, continuing throughout, and for one month after the last dose. That’s one primary form plus one secondary form.

Primary forms include IUDs (hormonal or copper), the implant, the injection, tubal ligation, a partner’s vasectomy, and combination hormonal methods – the pill, patch, or vaginal ring.

Secondary forms include male latex condoms, and a diaphragm or cervical cap used with spermicide, or the vaginal sponge.

Explicitly not acceptable: progestin-only “mini-pills,” female condoms, natural family planning or the rhythm method, withdrawal, breastfeeding, and cervical shields.

Note that two secondary forms don’t satisfy the requirement – condoms plus a diaphragm is not enough. You need at least one primary method. (If you’re considering two primary forms rather than a primary and a secondary, that’s worth discussing with your prescriber.)

On the question of hormone-free or non-invasive options: this is where the program is genuinely constraining, and it’s worth being straight about it. The copper IUD is the main hormone-free primary option, but it is a placed device. Combination pills, patch, and ring all involve hormones. Sterilization isn’t a reasonable option for a teenager. For a family that wants neither hormones nor a device, the realistic paths are the copper IUD, the abstinence pathway discussed below, or postponing isotretinoin. That’s a real conversation to have with your dermatologist and possibly a gynecologist, not a form to fill out.

The abstinence question, honestly

You may have read that iPLEDGE permits abstinence instead of two forms of contraception. That’s true. It’s also why some families are surprised when a dermatologist won’t accept it.

Here’s the nuance, in the program’s own words. The Prescriber Guide says abstinence “may be appropriate when it is a lifestyle choice, such as religious practice, and not just a social circumstance, such as not having a current partner.” It requires committing to no sexual contact that could result in pregnancy for one month before, throughout treatment, and one month after. And it states plainly that one of the most common reasons pregnancies occur in this program is patients engaging in sexual contact “when planning to be abstinent.”

So the program allows it while openly flagging it as a common failure route.

Why many providers decline it anyway. It’s worth understanding what you’re actually asking. A course of isotretinoin runs six months or more. Asking a provider to accept abstinence is asking them to accept, on trust, that nothing will change across that entire stretch – and to put their license, and a career that took most of their adult life to build, behind that assumption. Providers know how long six months is. They know that unintended things happen to people who fully intended otherwise.

But liability isn’t really the heart of it. “First, do no harm” includes preventing a birth defect that cannot be undone, and sparing a patient from ever facing the moment where she has to decide what to do about a pregnancy that occurred on this drug. A medication prescribed for acne can, very quickly, become the most devastating thing that ever happened to several people’s lives.

And the honest truth is that the providers who are strictest about contraception are usually the ones who have already seen it happen.

I have had to tell the parents of a 14-year-old girl that their daughter was pregnant while taking isotretinoin. They had assured me she was abstinent. I had insisted on oral contraceptives anyway – and the pills weren’t taken. There is no test that can tell you whether a fetus exposed to this drug has been affected. All I had to offer was a referral to an obstetrician. Sit for a moment with what it is to receive that news as a parent – or, in that instant, as a grandparent.

Calls like that are what keep dermatologists strict, because we know there was a point where it was preventable.

Yes, contraception carries its own risks, and those are worth discussing seriously. But they are being weighed against birth defects in the child of a teenage mother. That’s the comparison actually on the table.

So if a provider or the practice they work for declines the abstinence pathway, it isn’t distrust of you personally. Policies vary between providers and between practices, and they’re applied case by case – there is no blanket rule that patients under a certain age automatically qualify for abstinence.

One last piece of advice: pregnancy prevention on isotretinoin should be a substantive conversation, not a box someone checks quickly on the way out the door. If it isn’t getting that kind of attention, ask more questions. This is a medication worth getting from a dermatologist – someone who prescribes it regularly, knows the program cold, and will take the time to work through this with you properly.

To the parent whose daughter isn’t sexually active: the requirement isn’t a statement about your child. The program is built to hold across every patient regardless of what any individual family expects, because the consequence it’s preventing is severe and permanent.

For younger patients

Isotretinoin is FDA-approved for ages 12 and up. Worth knowing, though: a great deal of what dermatologists prescribe is used outside its labeled indication. That’s ordinary in this specialty rather than a red flag in itself, and treating a younger child is a decision made carefully, case by case, by a provider who knows the patient.

A few things usually happen first. Very early acne can warrant a hormonal workup to make sure something else isn’t driving it. And the risks of the medication – and, separately, the risks of contraception – get weighed against what severe nodulocystic acne actually does when it goes untreated.

That last part deserves emphasis, because it’s often underestimated: this is a scarring, disfiguring disease with real and lasting psychological consequences. It is not a cosmetic complaint, and the harm of undertreating it is not hypothetical.

In practice, a prepubertal patient may well be advised to take isotretinoin and advised not to start contraception, since many are not yet capable of reproduction. There’s no blanket rule that patients under a certain age are handled one way. Each case is individual, and it’s a conversation to have directly with your dermatologist rather than settle from a website.

When the program’s categories don’t match how you live

iPLEDGE sorts every patient into one of two groups – and it sorts by reproductive anatomy, not gender identity. The program’s own categories are “Patients Who Can Become Pregnant” and “Patients Who Can NOT Become Pregnant,” and the definitions are explicit: anyone born with a uterus and at least one ovary falls into the first group, whether they identify as a woman or as a man. A transgender man who hasn’t had a hysterectomy or oophorectomy is classified as able to become pregnant. A transgender woman is classified as unable.

That’s better explained in advance than discovered on a form. For a transgender man, being routed into monthly pregnancy testing and contraception counseling can feel invalidating, and that reaction is reasonable. Two things are worth knowing.

First, the current setup is an improvement on what it replaced. iPLEDGE used to sort patients by gender outright, which was both clinically imprecise and more alienating. Dermatologists specifically advocated for categories based on reproductive potential instead, so that transgender patients could be treated safely without being asked to misrepresent who they are. [5] The language is anatomical because the risk being managed is anatomical – not because the program has an opinion about anyone’s identity.

Second, and this is the part that genuinely matters medically: testosterone is not contraception. Many people on masculinizing hormone therapy stop having periods, and it’s a completely understandable assumption that this means pregnancy isn’t possible. It doesn’t. Ovulation can still occur, and pregnancy during testosterone therapy is documented. If you have a uterus and ovaries and you’re taking isotretinoin, the pregnancy-prevention requirements apply to you – for a real clinical reason, not a bureaucratic one. [6]

Good care here looks like a dermatologist who uses your name and pronouns, explains plainly why the paperwork reads the way it does, and coordinates with whoever manages your hormone therapy rather than treating the two as unrelated.

“How would they even know?” – on contraception verification

A fair question, asked often: nobody counts your pills. Pregnancy test results are entered by your prescriber from a certified lab, so those are verified. Your contraception methods are self-reported and confirmed by your prescriber in the system, and you re-attest by answering the comprehension questions each month.

It’s largely an honor system, and it’s worth understanding what that means. The program isn’t primarily built to catch people lying – it’s built to make sure nobody can claim they weren’t told, and to create a monthly checkpoint where you actively re-confirm you understand the stakes. iPLEDGE does monitor patient classification, and deliberately falsifying it is program non-compliance that can permanently end a prescriber’s ability to prescribe isotretinoin. But the real safeguard was never surveillance. It’s that the person taking the drug understands exactly what’s at risk and chooses to protect against it.

Why a pregnancy test every single month

Because the drug’s risk isn’t cumulative-dose dependent – a short exposure early in pregnancy can cause serious harm. A test from two months ago tells you nothing about today. The monthly test, tied to a 30-day supply, means there is never a stretch where someone is taking isotretinoin without a recent negative test on record.

There’s also a test about a month after the last dose – because the drug clears the body but the safe interval extends past the final capsule.

Can I do a second course?

Yes, and repeat courses are common and appropriate in the right situation.

The realistic expectation: after a single full course, roughly 70-80% of patients achieve long-term remission. [3] Relapse is more likely with certain patterns – acne that’s heavily comedonal, smoking, and being under 14 or over 25 at the time of treatment. [3] Notably, both younger and older patients relapse more often, which is exactly why someone treated as a young teen can find their acne returning as an adult.

So the person who did a course at 15, did well, and finds themselves at 24 with acne creeping back is describing an ordinary, well-documented outcome – not a failure, and not something they did wrong. A second course is a very reasonable discussion.

One practical warning: insurance may not agree. Coverage for repeat courses varies, and many plans will decline a second course that comes too soon after the first, or will require documentation of what was tried in between. That’s worth checking before you build a plan around it, because an approved course and an affordable course are not automatically the same thing.

A gentler note on a version of this question we hear sometimes: occasionally someone has completed several courses and is seeking another for acne that is, objectively, nearly gone – one blemish a year that they find intolerable. That’s worth naming kindly, because it’s common and it isn’t silly. Acne can leave a mark on how you see your face that outlasts the acne itself. But isotretinoin is not a maintenance drug and no course delivers permanent immunity from ever developing a pimple – that isn’t a realistic target for any treatment. If the distress is driven more by the fear of recurrence than by what is actually on your skin, that’s genuinely worth saying out loud to your dermatologist. It’s a common experience, it’s treatable, and the answer usually isn’t another course.

If your “acne” started in adulthood, it may not be acne

Here’s a distinction that changes the answer to a very common question.

One form of rosacea – papulopustular rosacea, sometimes called acneiform or acne rosacea – produces red bumps and pustules that can look nearly identical to acne. It typically appears in adulthood rather than at puberty, which is why it’s so often labeled “adult-onset acne.” Plenty of people carrying that label don’t have acne at all.

This matters because of what patients are usually asking: I have something that looks like acne – can isotretinoin clear me the way it does for real acne?

If it’s genuinely rosacea, the honest answer is: it can help considerably, but don’t expect a cure. Low-dose isotretinoin does work for difficult papulopustular rosacea – in a randomized controlled trial, 57% of patients reached the primary endpoint (at least a 90% reduction in papules and pustules) compared to 10% on placebo. [4] That’s a real effect.

But in the same trial, among patients followed afterward, 58% relapsed, at a median of about 15 weeks. [4] Rosacea is a chronic condition. Isotretinoin can control it, sometimes impressively, but the evidence doesn’t support it as a permanent cure the way it can be for acne.

So the practical version: if you had acne as a teenager and it’s back, isotretinoin may well offer lasting remission. If you never had acne and it appeared in your thirties, there’s a real chance it’s rosacea – and in that case isotretinoin is likely to be a temporizing measure rather than a one-and-done fix. Getting the diagnosis right first is what makes the expectation realistic.

Starting here, then going to college out of state

This comes up constantly, for sons and daughters alike, and the answer is the same for both: usually yes, with planning.

iPLEDGE accepts telemedicine visits. The constraints are elsewhere:

• Medical licensure. Your prescriber generally needs to be licensed in the state where *you are physically located* at the time of the visit. So a student who starts treatment at home and then leaves for school in another state needs a prescriber licensed in that state, or has to time visits for when they’re home, or transfers care.
• Insurance. Not all plans cover telemedicine visits with dermatology, and coverage varies considerably by plan and by state. A visit that’s clinically fine and program-compliant can still land you an unexpected bill. Check with your plan before you build a semester around it.
• The pharmacy. It has to be iPLEDGE-certified, and the prescription has to be picked up within the window, in the state where the student actually is. Sort this out before move-in, not during a 7-day window.

Practical advice: raise this before starting treatment, not in September. Course length is usually a matter of months, and sometimes the cleanest answer is timing the course to a summer, or deliberately starting it so it finishes before a move.

The short version

The program is genuinely burdensome and the burden is not pointless – it exists to prevent one specific, severe, permanent outcome. Most of the pain patients experience with it comes from misunderstanding the mechanics rather than from the rules themselves:

• If you can become pregnant, you can’t start the day you decide to – two negative tests and 30 days on both forms of contraception come first. Start the contraception conversation immediately; that’s the rate-limiting step.
• Everyone is on a monthly cycle. If you can become pregnant, you also have a 7-day pickup window each month, starting at the pregnancy test collection date.
• Don’t forget the monthly comprehension questions – they gate the prescription.
• Choose a pharmacy that’s good at this, and stay with it.
• Save your iPLEDGE ID number somewhere you’ll find it in eight months.
• Bloodwork is your dermatologist’s monitoring, not an iPLEDGE requirement.
• The 19-day lockout goes away November 15, 2026, along with at-home testing options.
• Check insurance on telemedicine and on repeat courses before you plan around either.

And if something goes sideways – a missed window, a pharmacy out of stock, a test scheduled wrong – call your dermatologist’s office rather than waiting for the next appointment. Most of these problems have solutions if they’re caught early, and every one of them is a problem the staff has handled many times before.

References

1. iPLEDGE REMS Prescriber Guide. Most recent update March 2023. ipledgeprogram.com
2. US Food and Drug Administration. iPLEDGE Risk Evaluation and Mitigation Strategy (REMS): approved modifications (February 2026) and implementation date change to November 15, 2026 (announced June 16, 2026). fda.gov
3. Rademaker M. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us? Australas J Dermatol. 2012;54(3):157-162. doi:10.1111/j.1440-0960.2012.00947.x
4. Sbidian E, Vicaut É, Chidiack H, et al. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea. J Invest Dermatol. 2016;136(6):1124-1129. doi:10.1016/j.jid.2016.01.025
5. Boos MD, Ginsberg BA, Peebles JK. Prescribing isotretinoin for transgender youth: A pledge for more inclusive care. Pediatr Dermatol. 2019;36(1):169-171. doi:10.1111/pde.13694
6. Radi R, Gold S, Acosta JP, Barron J, Yeung H. Treating Acne in Transgender Persons Receiving Testosterone: A Practical Guide. Am J Clin Dermatol. 2022;23(2):219-229. doi:10.1007/s40257-021-00665-w

Magnolia Forge Dermatology is coming to Raleigh, North Carolina. We are not yet scheduling appointments.

Medical content: William S. Farmer, MD · Last reviewed: July 2026